Request Info

Ask for our annual reports or more information
Email Us

Email Alerts

Sign up for email alerts
Email Alerts
Investor Relations


NASDAQ | VIVO (Common Stock)
01/18/194:00 p.m. ET
$16.82 + 0.20 (1.20%)
Stock chart for: VIVO.O.  Currently trading at $16.82 with a 52 week high of $19.84 and a 52 week low of $13.53.
Data provided by Nasdaq. Minimum 15 minutes delayed.

Corporate Profile

Meridian is a fully integrated life science company that develops, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products and diagnostic tests provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral and respiratory infections. Meridian’s diagnostic products are used outside of the human body and require little or no special equipment. More

Recent News View More

Meridian Bioscience Announces Preliminary First Quarter 2019 Revenue; First Quarter 2019 Financial Results Conference Call to be Held on January 24, 2019Read full article
Meridian Gets FDA Clearance for New Neonatal Saliva CMV TestRead full article
Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Sets Fiscal 2019 Cash Dividend Rate, and Provides Fiscal 2019 GuidanceRead full article

Events and Presentations View More

View upcoming events as well as all archived events and presentations.

Annual Meeting View More

View information about annual meetings, including reports and proxy statements

Most Viewed Links

News Releases
Events & Presentations
Annual Reports
SEC Filings
Board of Directors